CSIMarket
 


Koninklijke Philips Nv  (PHG)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Cumulative Koninklijke Philips Nv's Total Debt to Equity for Trailing Twelve Months Period

PHG's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

PHG Total Debt to Equity for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth -9.2 % -9.2 % -9.2 % -9.2 % -8.23 %
Y / Y Total Debt Growth -3.23 % -3.23 % -3.23 % -3.23 % 12.31 %
Total Debt to Equity for Trailing Twelve Months Period 0.58 0.57 0.56 0.56 0.55
Total Ranking # 1131 # # # # 2028
Seq. Equity Growth 0 % 0 % 0 % -9.2 % 0 %
Seq. Total Debt Growth 0 % 0 % 0 % -3.23 % 0 %


Total Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Despite repayements of liabilities of 0% in IV. Quarter, Total Debt to Equity for Trailing Twelve Months Period improved to 0.58, a new company high.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Laboratories industry 8 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Koninklijke Philips Nv. While total ranking remained unchanged compare to previous quarter at no. .

What is Debt to Equity Ratio?
PHG Charts and Quotes
Total Debt to Equity PHG in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 9
Sector # 140
S&P 500 # 1128


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.58 0.44 0.28
(Dec 31 2023)   (Dec 31 2018)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Medical Laboratories Industry Total Debt to Equity for Trailing Twelve Months Period
Radnet Inc   1.45 
Ge Healthcare Technologies Inc   1.43 
Inotiv Inc   1.40 
Malachite Innovations Inc   1.38 
Fortrea Holdings Inc   0.93 
Charles River Laboratories International inc   0.82 
Exagen Inc   0.76 
Exact Sciences Corporation  0.75 
Syneos Health Inc   0.75 
Quest Diagnostics Inc  0.68 
Koninklijke Philips Nv  0.57 
Hologic Inc  0.55 
Laboratory Corporation Of America Holdings  0.51 
Natera inc   0.50 
American Shared Hospital Services  0.49 
Icon Plc  0.44 
National Research Corporation  0.39 
Luna Innovations Inc  0.30 
Aclarion Inc   0.29 
Celcuity Inc   0.27 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com